Partners Capital Investment Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $575K | Sell |
6,934
-6,934
| -50% | -$575K | 0.02% | 123 |
|
|
2025
Q1 | $1.12M | Buy |
13,868
+6,934
| +100% | +$562K | 0.02% | 136 |
|
|
2024
Q4 | $624K | Sell |
6,934
-6,934
| -50% | -$624K | 0.02% | 112 |
|
|
2024
Q3 | $1.37M | Hold |
13,868
| – | – | 0.02% | 133 |
|
|
2024
Q2 | $1.29M | Buy |
13,868
+6,934
| +100% | +$643K | 0.02% | 136 |
|
|
2024
Q1 | $658K | Sell |
6,934
-8,099
| -54% | -$769K | 0.02% | 126 |
|
|
2023
Q4 | $1.34M | Buy |
15,033
+2
| +0% | +$179 | 0.03% | 134 |
|
|
2023
Q3 | $1.1M | Buy |
15,031
+6,950
| +86% | +$507K | 0.03% | 139 |
|
|
2023
Q2 | $672K | Buy |
8,081
+4,728
| +141% | +$393K | 0.01% | 157 |
|
|
2023
Q1 | $256K | Hold |
3,353
| – | – | 0.01% | 121 |
|
|
2022
Q4 | $278K | Hold |
3,353
| – | – | 0.01% | 121 |
|
|
2022
Q3 | $266K | Buy |
+3,353
| New | +$266K | 0.02% | 120 |
|